Depression is common, costly, debilitating, and associated with increased risk of suicide. It is
one of the leading global public health problems. Although existing available …

The high global prevalence of depression, together with the recent acceleration of remote
care owing to the COVID-19 pandemic, has prompted increased interest in the efficacy of …

Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of …

Background There is mixed evidence regarding the change in the prevalence of depression
in the general population over time. This study aimed to synthesise the evidence on studies …

In this epidemiological investigation, we assessed the prevalence of depression and anxiety
symptoms during the COVID-19 pandemic. A total of 10,061 adults participated in the study …

Background The psychological health of female sex workers (FSWs) has emerged as a
major public health concern in many low-and middle-income countries (LMICs). Key risk …

Anxiety and depression are the most common psychological symptoms in patients with
cancer, irrespective of disease stage, primary cancer site and phase of treatment. Symptoms …

Major depressive disorder (MDD) is a chronic, generally episodic and debilitating disease
that affects an estimated 300 million people worldwide, but its pathogenesis is poorly …

This study aimed to assess the levels of mental wellbeing and potential for clinical need in a
sample of UK university students aged 18–25 during the COVID-19 pandemic. We also …

Depression is a mood disorder with a high prevalence rate globally, which is associated with
abnormalities in 5-hydroxytryptamine (5-HT) metabolism. Emerging evidence suggests that …